These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32918830)

  • 21. Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design.
    Serrano D; Lipton RB; Scher AI; Reed ML; Stewart WBF; Adams AM; Buse DC
    J Headache Pain; 2017 Oct; 18(1):101. PubMed ID: 28980171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Munjal S; Buse DC; Fanning KM; Bennett A; Reed ML
    Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
    Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
    Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
    Lipton RB; Munjal S; Alam A; Buse DC; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
    Headache; 2018 Oct; 58(9):1408-1426. PubMed ID: 30341895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of headache to phase of the menstrual cycle among young women: a daily diary study.
    Johannes CB; Linet MS; Stewart WF; Celentano DD; Lipton RB; Szklo M
    Neurology; 1995 Jun; 45(6):1076-82. PubMed ID: 7783866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An observational study of self-reported migraine triggers and prospective evaluation of the relationships with occurrence of attacks enabled by a smartphone application (App).
    Casanova A; Vives-Mestres M; Donoghue S; Mian A; Martin PR
    Headache; 2022 Nov; 62(10):1406-1415. PubMed ID: 35670125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of menstrual vs nonmenstrual migraine: a post hoc, within-woman analysis of the usual-care phase of a nonrandomized menstrual migraine clinical trial.
    MacGregor EA; Victor TW; Hu X; Xiang Q; Puenpatom RA; Chen W; Campbell JC
    Headache; 2010 Apr; 50(4):528-38. PubMed ID: 20236340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Lipton RB; Serrano D; Nicholson RA; Buse DC; Runken MC; Reed ML
    Headache; 2013; 53(10):1548-63. PubMed ID: 23992516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Migraine Progression: A Systematic Review.
    Buse DC; Greisman JD; Baigi K; Lipton RB
    Headache; 2019 Mar; 59(3):306-338. PubMed ID: 30589090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validity of an illness severity measure for headache in a population sample of migraine sufferers.
    Stewart WF; Lipton RB; Simon D; Liberman J; Von Korff M
    Pain; 1999 Feb; 79(2-3):291-301. PubMed ID: 10068175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective Cohort Study of Caffeinated Beverage Intake as a Potential Trigger of Headaches among Migraineurs.
    Mostofsky E; Mittleman MA; Buettner C; Li W; Bertisch SM
    Am J Med; 2019 Aug; 132(8):984-991. PubMed ID: 31402050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Headache Triggers as Surprise.
    Turner DP; Lebowitz AD; Chtay I; Houle TT
    Headache; 2019 Apr; 59(4):495-508. PubMed ID: 30919414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing patient and parent recall of 90-day and 30-day migraine disability using elements of the PedMIDAS and an Internet headache diary.
    Heyer GL; Perkins SQ; Rose SC; Aylward SC; Lee JM
    Cephalalgia; 2014 Apr; 34(4):298-306. PubMed ID: 24126944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study).
    Starling AJ; Tepper SJ; Marmura MJ; Shamim EA; Robbins MS; Hindiyeh N; Charles AC; Goadsby PJ; Lipton RB; Silberstein SD; Gelfand AA; Chiacchierini RP; Dodick DW
    Cephalalgia; 2018 May; 38(6):1038-1048. PubMed ID: 29504483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
    Dodick DW; Turkel CC; DeGryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF;
    Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post-Hoc Analyses on the First 3 Weeks of Treatment.
    Silberstein SD; Rapoport AM; Loupe PS; Aycardi E; McDonald M; Yang R; Bigal ME
    Headache; 2019 Mar; 59(3):383-393. PubMed ID: 30450545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of avoiding known triggers, embracing protectors, and adhering to healthy lifestyle recommendations in migraine prophylaxis: Insights from a prospective cohort of 1125 people with episodic migraine.
    Casanova A; Vives-Mestres M; Donoghue S; Mian A; Wöber C
    Headache; 2023 Jan; 63(1):51-61. PubMed ID: 36651502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial.
    Mulleners WM; Kim BK; Láinez MJA; Lanteri-Minet M; Pozo-Rosich P; Wang S; Tockhorn-Heidenreich A; Aurora SK; Nichols RM; Yunes-Medina L; Detke HC
    Lancet Neurol; 2020 Oct; 19(10):814-825. PubMed ID: 32949542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating migraineurs' preferences for migraine treatment outcomes using a choice experiment.
    Gonzalez JM; Johnson FR; Runken MC; Poulos CM
    Headache; 2013; 53(10):1635-50. PubMed ID: 23808578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circadian variations in the clinical presentation of headaches among migraineurs: A study using a smartphone headache diary.
    Park JW; Cho SJ; Park SG; Chu MK
    Chronobiol Int; 2018 Apr; 35(4):546-554. PubMed ID: 29283309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.